androstenediol has been researched along with flutamide in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellavance, E; Luu-The, V; Poirier, D | 1 |
Dauvois, S; Labrie, F | 1 |
Bélanger, A; Brochu, M; Cusan, L; Dupont, A; Labrie, F | 1 |
Bégin, D; Labrie, F; Luthy, IA | 1 |
Boccuzzi, G; Brignardello, E; Di Monaco, M; Gallo, M; Gatto, V; Leonardi, L; Pizzini, A | 1 |
Chang, C; Lardy, H; Messing, E; Miyamoto, H; Yeh, S | 1 |
Carter, WH; Huynh, PN; Loria, RM | 1 |
Jasso-Kamel, J; Montaño, LM; Navarrete, E; Perusquía, M | 1 |
Andruszkow, H; Frink, M; Hildebrand, F; Krettek, C; Mommsen, P; Neunaber, C; Zeckey, C | 1 |
1 review(s) available for androstenediol and flutamide
Article | Year |
---|---|
Immunomodulation in polytrauma and polymicrobial sepsis - where do we stand?
Topics: Androstenediol; Animals; Dehydroepiandrosterone; Finasteride; Flutamide; Humans; Immunomodulation; Lipopeptides; Multiple Trauma; Sepsis | 2011 |
8 other study(ies) available for androstenediol and flutamide
Article | Year |
---|---|
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Androstenediol; Androstenediols; Androstenedione; Animals; Aromatase; Female; Flutamide; Mammary Neoplasms, Experimental; Ovariectomy; Rats; Rats, Inbred Strains; Silicone Elastomers | 1989 |
Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Androsterone; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dehydroepiandrosterone; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Kinetics; Luteinizing Hormone; Male; Pregnenolone; Progesterone; Prolactin; Prostatic Neoplasms; Testosterone; Triptorelin Pamoate | 1988 |
Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro.
Topics: Androgens; Androstenediol; Androstenediols; Androstenedione; Animals; Cell Line; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Flutamide; Growth; Male; Mammary Neoplasms, Experimental; Mice; Tumor Cells, Cultured | 1988 |
5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.
Topics: Androstenediol; Breast Neoplasms; Cell Division; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Flutamide; Humans; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1994 |
Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells.
Topics: Androgens; Androstane-3,17-diol; Androstenediol; Anilides; Flutamide; Humans; Male; Mutation; Nitriles; Nuclear Receptor Coactivators; Oncogene Proteins; Prostatic Neoplasms; Protein Conformation; Receptors, Androgen; Steroids; Testosterone; Tosyl Compounds; Trans-Activators; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 1998 |
17 alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell lines.
Topics: Anabolic Agents; Androgen Antagonists; Androgen Receptor Antagonists; Androstenediol; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogen Receptor alpha; Flutamide; Humans; Models, Biological; Receptors, Androgen; Receptors, Estrogen; Stereoisomerism; Tumor Cells, Cultured | 2000 |
Androgens induce relaxation of contractile activity in pregnant human myometrium at term: a nongenomic action on L-type calcium channels.
Topics: Androgen Antagonists; Androgens; Androstenediol; Androsterone; Calcium Channels, L-Type; Dehydroepiandrosterone; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Flutamide; Humans; In Vitro Techniques; Isometric Contraction; Muscle Relaxation; Muscle, Smooth; Myometrium; Pregnancy; Protein Synthesis Inhibitors; Statistics, Nonparametric; Testosterone; Uterine Contraction | 2005 |